Concepedia

Ibrutinib-induced lymphocytosis in patients with chronic lymphocytic leukemia: correlative analyses from a phase II study

Sarah E. M. Herman, Carsten Utoft Niemann, Mahfooz Farooqui, Jeffrey A. Jones, Rashida Z. Mustafa, Andrew Lipsky, Nakhle S. Saba, Sabrina Martyr, S. Soto, Joseph M. Valdez,

Leukemia · 2014 · 190 citations · 40 references

DOIFull text

Open access

Concepts

References

40

Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia

John C. Byrd, Richard R. Furman, Steven Coutré et al. · New England Journal of Medicine · 2013 · 2.2K citations · Full text

, , +12

Prediction of blood volume in normal human adults.

S. B. Nadler, Ted Bloch · PubMed · 1962 · 2.1K citations

, , +12

Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma

Michael Wang, Simon Rule, Peter Martin et al. · New England Journal of Medicine · 2013 · 1.7K citations · Full text

, , +17

Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

R. Eric Davis, Vu N. Ngo, Georg Lenz et al. · Nature · 2010 · 1.6K citations · Full text

, , +14

Bruton Tyrosine Kinase Inhibitor Ibrutinib (PCI-32765) Has Significant Activity in Patients With Relapsed/Refractory B-Cell Malignancies

Ranjana H. Advani, Joseph J. Buggy, Jeff P. Sharman et al. · Journal of Clinical Oncology · 2012 · 1.1K citations · Full text

, , +17